Observational Clinical Trial Underway. Click to find out more.
  • About us
    TeamOur StoryDemoOur Science
  • How it works
    Our UniquenessDisease ModelsDemoWhite Papers
  • Participate
    Become Clinical PartnerParticipate in a TrialDemo
  • Investor
  • Media
    NewsConferencesIndustry InsightsBlog
  • CONTACT US

Trending Industry insights

Gradient Biomodeling Announces Collaboration Agreement to Advance Discovery of New Antivirals for Neglected Tropical Diseases

Industry
10/24/2023

AI Offers Alternatives to Genetic Testing to Make Disease Detection More Accessible.

Industry
10/2/2023

Precision Medicine Has Been Overhyped

Industry
9/28/2023

Illumina taps Agilent's Jacob Thaysen as CEO

Industry
9/5/2023

Scientists Discover 'Pure Math' Is Written Into Evolutionary Genetics

Technology
9/5/2023

Machine Learning’s Potential to Improve Medical Diagnosis

Technology
11/10/2022

Ask the MD: Does Parkinson’s Have a Signature Scent?

Industry
10/4/2022

Artificial Intelligence in Health Care: Benefits and Challenges of Machine Learning Technologies for Medical Diagnostics

Technology
9/29/2022

How artificial intelligence might disrupt diagnostics in hematology in the near future

Technology
6/8/2021

Improving the accuracy of medical diagnosis with causal machine learning

Technology
3/31/2021

From Nose to Diagnostics: Development of an Accessible Screening Platform for Early Diagnosis of Parkinson's Disease

Industry

Latest Luventix news

Conferences

December 5, 2024

Vern Norviel Joins Luventix Advisory Board

Read more
October 28, 2024
–
October 30, 2024

LD Micro Main Event XVII 2024 Conference Presentation

Learn more
ABOUT
TeamOur StoryOur ScienceInvestor
HOW IT WORKS
Our UniquenessDisease modelsDemoWhite Papers
PARTICIPATE
Become Clinical PartnerParticipate in a Trial
MEDIA
NewsConferencesTrending Industry NewsBlog
CONTACT US
Send us a message

IR@luventix.com

---

HQ
Luventix
45 Via Brianza, Ste 100 #200,
Henderson, NV 89011
‍

Operations
250 W. Bobwhite Court, Suite 120
Boise, ID 83706

Copyright © 2023 - 2025 Luventix Inc. All rights reserved.
Terms of usePrivacy policy